Delhi team fabricates a sensor to detect drug-resistant leukaemia

A highly sensitive carbon nanotube-based sensor capable of detecting multidrug-resistant myeloid leukemia cells even when present at very low concentration of 10 cells per ml has been fabricated by Delhi-based researchers. Using chemical vapour deposition technique, the team led by Prof. S.S. Islam from the Centre for Nanoscience and Nanotechnology at the Jamia Millia Islamia … Continue reading Delhi team fabricates a sensor to detect drug-resistant leukaemia

Advertisement

IISc’s blood cancer drug shows early promise

  Researchers at the Indian Institute of Science, Bengaluru have synthesised a small molecule that shows a degree of promise as an anticancer agent. In particular, the inhibitor was effective against leukaemia. The work was done in collaboration with researchers from the University of Mysore. The molecule (benzothiazole derivative), codenamed 5g, was found to be … Continue reading IISc’s blood cancer drug shows early promise

IIT Madras’ first step to develop cheaper cancer diagnostic alternative

A team of researchers from the Indian Institute of Technology (IIT) Madras has developed a cheaper yet reliable alternative for diagnosing leukaemia and colorectal cancer. Like monoclonal antibodies which are currently used for cancer diagnostics, the fusion protein developed by the researchers has high specificity and sensitivity. The results were recently published in the journal … Continue reading IIT Madras’ first step to develop cheaper cancer diagnostic alternative

IISc: Sapota’s anticancer properties studied

Now, sapota joins the list of fruits that have proven anticancer properties. Proof of principle study using human cancer cell lines and mice induced with breast cancer has shown that certain chemicals in sapota fruit can inhibit tumour progression. The study was undertaken by a team of scientists from the Indian Institute of Science (IISc) … Continue reading IISc: Sapota’s anticancer properties studied

A drug to treat leukaemia shows promise in mice

Published in The Hindu on March 14, 2013   A new monoclonal antibody that can treat leukaemia and a few solid tumours, like ovarian cancer, is a step closer. Leukaemia is largely incurable in adults.  This is because the cancer-associated proteins — the target of monoclonal antibodies — are safely secured inside cells, and are beyond … Continue reading A drug to treat leukaemia shows promise in mice

Managing diseases using stem cells

Published in The Hindu on February 21, 2008 Cell based diseases such Parkinson’s, Alzheimer’s and diabetes were seen as the first candidates for being cured using stem cell transplantation. There is a probability that it would be possible one day. But some scientists are beginning to think that it will take another 15 years for … Continue reading Managing diseases using stem cells

Chernobyl: the final word is yet to be said

Published in The Hindu on April 27, 2006 "An accident has occurred at the Chernobyl nuclear power plant. One of the reactors has been 'damaged.'" These were some of the statements made by the Soviet authorities when confronted with evidence by Sweden. And this came more than 30 hours after the accident had occurred. Playing … Continue reading Chernobyl: the final word is yet to be said

Treating cancer the nanotechnology way

Published in The Hindu on August 4, 2005 The battle against cancer has entered a new phase and if Ram Sasisekharan and his team's work proves to be efficacious in humans, treating some forms of cancer is likely to become effective, safe and truly path breaking. While they have essentially used the existing methods of … Continue reading Treating cancer the nanotechnology way

Editorial: Cord blood banking

Seventeen years after the first successful transplantation of stem cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a source of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that … Continue reading Editorial: Cord blood banking